Joseph Conrad | Senior Technology Analysis & Marketing Specialist
NIH

Dr. Joseph M. Conrad III, Esq. received his Ph.D. in biochemistry from American University and his JD from George Washington University Washington College of Law.  He’s a former U.S. Patent & Trademark Office Patent Examiner and spent several years working with two Washington DC patent law firms doing patent preparation and prosecution.  He joined the NIH’s National Institute of Allergy and Infectious Diseases’ (NIAID’s) Office of Technology Development (OTD) in 2003, where he was responsible for the management of NIAID’s patent portfolio and educating scientists on patent related matters.  In 2006, he joined the National Cancer Institute’s (NCI’s) Technology Transfer Center (TTC), where he was responsible for negotiating technology transfer agreements and overseeing invention activities for the National Institute of Child Health and Human Development (NICHD).  In 2016, he joined TTC’s Technology Analysis and Marketing Unit (TAMU) and is now a Senior Technology Analysis & Marketing Specialist.  In this position, Dr. Conrad is responsible for developing and improving TTC’s technology marketing activities, by interacting with private sector stakeholders to increase visibility of NIH developed technologies, creating awareness of technology licensing and partnering opportunities with the NIH, and building relationships with private sector stakeholders.